Aprea Therapeutics, Inc. Rings the Opening Bell in Celebration of its IPO
ABOUT THIS EVENT
Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Christian S. Schade, President & CEO, rang the Opening Bell.